Suchergebnisse
EXC vs. FE: Which Utility Stock Offers Stronger Potential in 2026?
The Zacks Utility - Electric Power industry, supported by its regulated structure offer, stable returns and long-term earnings. Utilities operate under a regulated framework, enabling companies to
Is MasterCard (MA) a Solid Growth Stock? 3 Reasons to Think "Yes"
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
Analog Devices (ADI) is an Incredible Growth Stock: 3 Reasons Why
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't
UBER Stock Plunges 23.4% in 6 Months:Time to Hold or Fold?
Shares of Uber Technologies UBER) have declined 23.4% over the past six months against the Zacks Internet-Services industry’s growth of 20.7%. However, it outperformed fellow industry players, Lyft
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%
Momentum ETF (SPMO) Hits New 52-Week High
Invesco S&P 500 Momentum ETF SPMO is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 46.84% from its 52-week low price of $84.86 per share.
Surging Earnings Estimates Signal Upside for Peloton (PTON) Stock
Peloton (PTON) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its
Earnings Estimates Rising for Murphy Oil (MUR): Will It Gain?
Murphy Oil (MUR) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd
HSBC Launches TDS in U.S., Boosts Digital Payments & Global Liquidity
HSBC Holdings plc HSBC has introduced its Tokenized Deposit Service (TDS) in the United States to enable faster and smoother money transfers using blockchain technology. The move represents the
Terreno Announces Completion of Property Development in Hialeah
Terreno Realty Corporation TRNO announced that it recently completed the development and stabilization of Countyline Corporate Park Phase IV Building 34 in Hialeah, FL, for a total investment of
Why Corpay (CPAY) Could Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Corpay (CPAY)
Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Royalty Pharma
Why Ally Financial (ALLY) Could Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ally Financial (ALLY), which belongs to
Why Honeywell International (HON) Could Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Honeywell
Shopify Trades 37% Below 52-Week High: Is the Stock Still a Buy?
Shopify SHOP shares closed at $114.97 on Monday, which was 36.9% lower than the 52-week high of $182.19 it hit on Oct. 29. SHOP shares have dropped 28.6% year to date, underperforming the broader
MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes
Medline Inc. (MDLN recently received a warning letter from the FDA, citing multiple violations related to manufacturing and quality system processes at its New York facility. The regulatory action
How Will Visa's Neat Partnership Help Boost Engagement and Growth?
Visa Inc. V recently announced a new partnership with Neat to enhance the insurance and medical assistance services embedded within its cards. The collaboration underscores a broader move toward


